Soluble urokinase plasminogen activator receptor (suPAR) as an early predictor of severe respiratory failure in patients with COVID-19 pneumonia.

Rovina, Nikoletta; Akinosoglou, Karolina; Eugen-Olsen, Jesper; Hayek, Salim; Reiser, Jochen; Giamarellos-Bourboulis, Evangelos J

Soluble urokinase plasminogen activator receptor (suPAR) as an early predictor of severe respiratory failure in patients with COVID-19 pneumonia.

Rovina, Nikoletta; Akinosoglou, Karolina; Eugen-Olsen, Jesper; Hayek, Salim; Reiser, Jochen; Giamarellos-Bourboulis, Evangelos J.

Rovina N; 1st Department of Pulmonary Medicine and Intensive Care Unit, National and Kapodistrian University of Athens, Medical School, 115 27, Athens, Greece.
Akinosoglou K; Department of Internal Medicine, University of Patras, Medical School, 265 04, Rio, Greece.
Eugen-Olsen J; Clinical Research Centre, Copenhagen University Hospital, Hvidovre, Denmark.
Hayek S; Department of Medicine, University of Michigan, Ann Arbor, MI, 48103, USA.
Reiser J; Department of Medicine, Rush University Medical Center, 1717 West Congress Parkway, Chicago, IL, 60612, USA. jochen_reiser@rush.edu.
Giamarellos-Bourboulis EJ; 4th Department of Internal Medicine, National and Kapodistrian University of Athens, Medical School, 124 62, Athens, Greece. egiamarel@med.uoa.gr.

Crit Care ; 24(1): 187, 2020 04 30.

Article in English | MEDLINE | ID: covidwho-144003

Subject(s)

Coronavirus Infections/diagnosis; Pneumonia, Viral/diagnosis; Receptors, Urokinase Plasminogen Activator/blood; Respiratory Insufficiency/diagnosis; Aged; Betacoronavirus; Biomarkers/blood; COVID-19; COVID-19 Testing; Clinical Laboratory Techniques; Female; Humans; Immunoenzyme Techniques; Male; Middle Aged; Pandemics; Respiratory Insufficiency/virology; SARS-CoV-2

Keywords

COVID-19; Prognosis; Respiratory failure; suPAR

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Respiratory Insufficiency / Coronavirus Infections / Receptors, Urokinase Plasminogen Activator Type of study: Diagnostic study / Prognostic study Limits: Aged / Female / Humans / Male / Middle aged Language: English Journal: Crit Care Year: 2020 Document Type: Article Affiliation country: S13054-020-02897-4

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google